Clinical Study
Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience
Table 2
The relationship between potential risk factors and febrile UTI rate assessed with multivariate logistic regression analysis.
| Risk factor |
Febrile UTI (%) | OR | 95% CI | P | + | − |
| Greater PSA levela | 2.1 | 2.0 | 0.97 | 0.56–1.49 | 0.72 | Greater ageb | 2.0 | 2.1 | 0.91 | 0.59–1.58 | 0.90 | ≥12 core biopsy | 2.1 | 1.9 | 0.61 | 0.25–1.48 | 0.27 | Out-patient clinic | 1.9 | 2.1 | 0.93 | 0.38–2.32 | 0.88 | Prostate cancer | 1.5 | 2.3 | 1.46 | 0.80–2.65 | 0.22 | Chronic inflammation | 2.5 | 2.0 | 1.07 | 0.42–2.75 | 0.89 | Levofloxacin prophylaxis | 1.0 | 3.7 | 3.74 | 2.26–6.20 | <0.001 |
|
|
Greater than median PSA level.
bGreater than median age.
|